Status:
COMPLETED
mobiCARE™ ECG Monitoring System
Lead Sponsor:
Seers Technology Co., Ltd.
Collaborating Sponsors:
Eminence Clinical Research, Inc.
Conditions:
ECG Monitoring
Eligibility:
All Genders
18+ years
Brief Summary
Evaluation of the mobiCARE™ ECG Monitoring System Electrode Placement Positioning Limits in a Prospective, Non-Randomized, Single-Center U.S. Study
Detailed Description
The purpose of the Seers Technology Company Ltd. sponsored study using the mobiCARE™ ECG Monitoring System is to document the variability and interpretability of heart rhythm tracings from the nominal...
Eligibility Criteria
Inclusion
- Male and female adults ≥ 18 years of age;
- Willing and able to provide informed consent;
- Able to speak and read English fluently;
- Participant is ambulatory.
Exclusion
- Patients with cardiac pacemaker;
- Patients with cardioverter defibrillator;
- Patients with other implantable electric devices;
- Currently or has a medical history of skin cancer, rash, skin disorder, keloid, and/or any injury in the chest area;
- Patients with symptomatic episodes where variations in cardiac performance could result in immediate danger to the patient;
- Patients with known history of life-threatening arrhythmias;
- Use in combination with external cardiac defibrillators or high frequency surgical equipment near strong magnetic fields or devices such as MRI;
- Patients with neuro-stimulator, as it may disrupt the quality of ECG data;
- Critical care patients;
- Chest pain at the time of presentation for the study.
Key Trial Info
Start Date :
January 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 16 2025
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT06896734
Start Date
January 1 2025
End Date
March 16 2025
Last Update
May 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MCB Clinical Research Centers, LLC
Colorado Springs, Colorado, United States, 80910